Navigation Links
Takeda and Arbor Announce a Licensing Agreement for EDARBI and EDARBYCLOR
Date:9/12/2013

DEERFIELD, Ill. and OSAKA, Japan and ATLANTA, Sept. 12, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and Arbor Pharmaceuticals Ireland Ltd., a wholly-owned subsidiary of Arbor Pharmaceuticals, LLC ("Arbor") announced today that Takeda and Arbor have entered into a license, development and commercialization agreement. It will provide Arbor with exclusive rights to market and sell EDARBI (azilsartan medoxomil) and EDARBYCLOR (azilsartan medoxomil and chlorthalidone) in the U.S. market effective September 12, 2013.

Under the terms of the agreement, Arbor will have exclusive rights to promote and sell EDARBI and EDARBYCLOR in the United States. In return, Takeda will receive an upfront payment along with a series of future milestone and royalty payments based upon sales of the EDARBI family of products.

"This is an opportunity to capture the value that we've created in developing and launching the EDARBI family of products while positioning us to optimize our commercial resources to support our recent and anticipated launches of new products," said Douglas Cole, president, Takeda Pharmaceuticals U.S.A., Inc. "We are pleased to entrust the EDARBI family in the United States to Arbor who will continue to ensure EDARBI products are available as a treatment option to patients with hypertension. Takeda maintains its global commitment to find new therapies and expand upon the cardiovascular metabolic franchise. The EDARBI family of products remains a priority for a variety of Takeda's markets globally."

"We are excited about our acquisition of U.S. rights to EDARBI and EDARBYCLOR and look forward to representing these important brands to patients and healthcare providers," said Ed Schutter, president & CEO of
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Takedas New Investigational Drug Vedolizumab is Granted Priority Review Status by U.S. Food and Drug Administration for Ulcerative Colitis
2. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
3. Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimers Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm
4. Takeda Launches New Subsidiary in Peru
5. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
6. Among New Agents Entering the Unipolar Depression Market Over the Next Decade, Lundbeck/Takeda Pharmaceuticals Brintellix Has Blockbuster Potential
7. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
8. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
9. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
10. Takeda to Acquire Inviragen, Inc.
11. Takeda Responds to Verdict in Diabetes Drug Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... BETHESDA, Md. , Aug. 19, 2014  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... note offering announced last Thursday, August 14, 2014, has ... and are convertible at $7.30 per share of common ... 3 months, to purchase up to an additional 30% ...
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Contract Manufacturing - Global Strategic Business Report" report ... the worldwide markets for Pharmaceutical Contract Manufacturing in US$ ... and IV solutions), Solid Dosage Forms (Tablets and Capsules), ... Creams & Ointments). The report provides separate ...
(Date:8/19/2014)... Research and Markets has announced the addition of ... Report" report to their offering. This ... in US$ Million by the following Brands: Humatrope, Norditropin, Genotropin, ... comprehensive analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual ...
Breaking Medicine Technology:NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 3Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Global Human Growth Hormone Drugs - Strategic Business Report 2014 2
(Date:8/19/2014)... the brain involved in multitasking and ways to train ... the IUGM Institut universitaire de griatrie de Montral and ... to better predict the effectiveness of this training. Cooking ... the Web, or driving while listening to a radio ... our daily lives. Unfortunately, it decreases with age, which ...
(Date:8/19/2014)... Recently, UWDress.com, a professional company of women’s dresses and related ... formal evening dresses . Additionally, the firm has launched a ... moment, all of them can be ordered at discounted rates, ... until August 27, 2014. , The company puts much ... that women of all shapes can be graceful and charming. ...
(Date:8/19/2014)... August 19, 2014 “ Inbox Blueprint ... course designed to provide users with the tools necessary ... marketing techniques and strategies. The course which was ... of excitement throughout the internet marketing world. The commotion ... HonestyFirstReviews.com's Tiffany Hendricks prompting an updated review of the ...
(Date:8/19/2014)... NV (PRWEB) August 19, 2014 The ... the 2nd Annual Southwest CannaBusiness Symposium on ... Plaza Hotel & Casino in Las Vegas. , Featuring ... State Senator Tick Segerblom (D-Las Vegas), the event will ... practices, and the work NCIA is doing federally to ...
(Date:8/19/2014)... Grande Naturals, LLC is proud ... the 2014 Independent Cosmetics Manufacturers & Distributors Award ... position in “Product Innovation; Product Color Cosmetic” for ... includes a lash enhancement serum, GrandeLINER™. GrandeLINER™ ... , This all-new eyeliner is a ...
Breaking Medicine News(10 mins):Health News:Targeted brain training may help you multitask better 2Health News:Cheap Plus Size Formal Evening Dresses Announced By UWDress.com 2Health News:Anik Singal’s “Inbox Blueprint” Review Released By HonestyFirstReviews.com 2Health News:SATURDAY IN LAS VEGAS: U.S. Rep. Dina Titus, State Sen. Tick Segerblom Keynote National Cannabis Industry Association Southwest CannaBusiness Symposium 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 3
... ... are turning to unexpected sources for natural remedies and ways to conserve. Humidifiers , ... and relieving symptoms of colds and the flu through proper humidification. As a result ... ...
... ... advisory committee in pain management, , ... Maywood NJ (PRWEB) October 13, 2009 -- Advanced Data Systems (ADS) welcomes ... is a Managing Partner of Pain Centers of America, PA specializing in interventional pain management. ...
... ... of his new state-of-the-art website designed to provide comprehensive information on gastric sleeve surgery, ... obese men and women lose significant amounts of weight and reduce the risk of ... ...
... ... quality EMS bags and backpacks and other trauma bags for medical professionals. The updated website ... meet the growing demands of their customers in the medical community. , ... (PRWEB) October 13, 2009 -- Colorado Cases ...
... ... 15 to Dec. 31—for Medicare-eligible individuals to evaluate and choose the plan that best ... ... seniors and people with disabilities will be required to choose new healthcare coverage during ...
... team of scientists at the National Cancer Institute (NCI) in ... yield valuable information on how to diagnose and treat human ... team discusses an ongoing initiative in which spontaneously occurring cancers ... of new cancer drugs, devices and imaging strategies for human ...
Cached Medicine News:Health News:Humidifiers -- Not Just for Children Anymore -- AchooAllergy.com Announces All New Humidifiers Offering 2Health News:Humidifiers -- Not Just for Children Anymore -- AchooAllergy.com Announces All New Humidifiers Offering 3Health News:ADSC's Pain Management Reinforcement 2Health News:Dallas, Texas Lap-Band Surgeon Announces New Website to Educate Patients on the Lap-Band System and Other Advanced Weight Loss Solutions 2Health News:Dallas, Texas Lap-Band Surgeon Announces New Website to Educate Patients on the Lap-Band System and Other Advanced Weight Loss Solutions 3Health News:Colorado Cases Launches New Website to Add More Custom Cases for Medical Professionals and Expand Services 2Health News:Colorado Cases Launches New Website to Add More Custom Cases for Medical Professionals and Expand Services 3Health News:Healthcare Reform, Coverage Changes Highlight Key Questions for Medicare Annual Enrollment Season, Allsup Says 2Health News:Healthcare Reform, Coverage Changes Highlight Key Questions for Medicare Annual Enrollment Season, Allsup Says 3Health News:Healthcare Reform, Coverage Changes Highlight Key Questions for Medicare Annual Enrollment Season, Allsup Says 4Health News:Healthcare Reform, Coverage Changes Highlight Key Questions for Medicare Annual Enrollment Season, Allsup Says 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: